Mosemedi Co., Ltd. has developed the Low Intensity Variance Ultrasound (LIVU) for inducing cancer reverse mutation guided system, which can treat capillaries based on diffuse ultrasound and multi-diffuse beams to overcome the limitations of ultrasound medical technology.
Mosemedi is a company that has significantly upgraded the functionality of its products using modern science and technology.
Since its establishment, the company has held 9 registered patents and 32 registered utility models, positioning itself as a leading medical device manufacturer in Korea.
In 2011, Mosemedi received ISO 9001/14001 international quality and environmental certification and was recognized as a medical device manufacturing venture company. The company also established the Mose Brain Engineering Research Institute to develop products that cater to the aging society of the 21st century.
In 2012, the company was selected as a promising small and medium-sized export company and has been exporting abroad. Preparations for exports to Southeast Asia and the Middle East are also underway. Mosemedi is a company that strives to elevate Korean technology to the world's best for the health of humanity.
A company trusted by customers
We deliver impressive daily experiences with excellent quality and brand value.
Global Product Brand
A medical device company leading the global market by combining modern medical technology.
COMPANY INFO
CEO Daehee, Cho
COMPANY NAME MOSE MEDI
Headquarters
Room 402, 253, Sanho-daero, Gumi-si, Gyeongsangbuk-do, Republic of Korea
TEL : +82-54-461-4737 FAX : +82-54-461-4738 E-mail : mosemedi@naver.com
※ Unauthorized reproduction or use is prohibited by copyright law (Article 97, Paragraph 5).
The copyright of the production belongs to our company and violators will be punished.
COPYRIGHT(C) 2023 MOSE MEDI Co., LTD. ALL RIGHTS RESERVED.
